xyosted (autoinjector) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Xyosted (autoinjector), and when can generic versions of Xyosted (autoinjector) launch?
Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. There are twenty-three patents protecting this drug.
This drug has ninety-four patent family members in fourteen countries.
The generic ingredient in XYOSTED (AUTOINJECTOR) is testosterone enanthate. There are sixty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Xyosted (autoinjector)
A generic version of xyosted (autoinjector) was approved as testosterone enanthate by WATSON PHARMS INC on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for xyosted (autoinjector)?
- What are the global sales for xyosted (autoinjector)?
- What is Average Wholesale Price for xyosted (autoinjector)?
Summary for xyosted (autoinjector)
| International Patents: | 94 |
| US Patents: | 23 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Patent Applications: | 2,630 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for xyosted (autoinjector) |
| DailyMed Link: | xyosted (autoinjector) at DailyMed |
-patent-expirations.png "xyosted (autoinjector) drug patent expirations")
Pharmacology for xyosted (autoinjector)
| Drug Class | Androgen |
| Mechanism of Action | Androgen Receptor Agonists |
US Patents and Regulatory Information for xyosted (autoinjector)
xyosted (autoinjector) is protected by twenty-three US patents.
Patents protecting xyosted (autoinjector)
Needle assisted jet injection administration of testosterone compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY
Injection device with cammed RAM assembly
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Prefilled syringe injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Testosterone ester triglyceride formulations
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Needle assisted jet injection administration of testosterone compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY
Needle assisted injection device having reduced trigger force
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Injection device with cammed ram assembly
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Needle assisted injection administration of testosterone compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY
Hematocrit modulation through needle assisted jet injection of testosterone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY
Syringe shock absorber for use in an injection device
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Prefilled syringe injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY
Prefilled syringe jet injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Prefilled syringe jet injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Prefilled syringe jet injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Prefilled syringe jet injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Prefilled syringe jet injector
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Needle assisted jet injection device having reduced trigger force
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Needle assisted jet injection administration of testosterone compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for xyosted (autoinjector)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-003 | Sep 28, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-001 | Sep 28, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-002 | Sep 28, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| Antares Pharma Inc | XYOSTED (AUTOINJECTOR) | testosterone enanthate | SOLUTION;SUBCUTANEOUS | 209863-001 | Sep 28, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for xyosted (autoinjector)
See the table below for patents covering xyosted (autoinjector) around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | 2024045264 | テストステロンエステルトリグリセリド製剤 | ⤷ Sign Up |
| Spain | 2886553 | ⤷ Sign Up | |
| Japan | 2016507305 | トリガ力を低減した針支援式ジェット注射装置 | ⤷ Sign Up |
| Germany | 69921704 | ⤷ Sign Up | |
| South Korea | 20120028294 | HAZARDOUS AGENT INJECTION SYSTEM | ⤷ Sign Up |
| Japan | 2015516845 | テストステロン組成物の針支援式ジェット注入投与 | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
